The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating the potential of micronuclei DNA from erythrocytes for early detection or recurrence risk prediction of colorectal cancer.
 
Xingyun Yao
No Relationships to Disclose
 
Haobo Sun
No Relationships to Disclose
 
Yurong Jiao
No Relationships to Disclose
 
Xiangxing Kong
No Relationships to Disclose
 
Chengcheng Liu
No Relationships to Disclose
 
Jie Pan
No Relationships to Disclose
 
Fangchao Zhu
No Relationships to Disclose
 
Fei Meng
No Relationships to Disclose
 
Honghao Liang
No Relationships to Disclose
 
Yanfei Cao
No Relationships to Disclose
 
Jun Li
No Relationships to Disclose
 
Kefeng Ding
No Relationships to Disclose
 
Xiaofei Gao
Employment - Westlake Therapeutics
Leadership - Westlake Therapeutics
Stock and Other Ownership Interests - Westlake Therapeutics
Patents, Royalties, Other Intellectual Property - 1. METHOD FOR PREPARING MATURE RED BLOOD CELLS IN VITRO USING PERIPHERAL BLOOD; US17/430020; Inventors: Xiaofei Gao, Yanjie Huang, Qing Zhang. 2. GENETICALLY ENGINEERED ERYTHROCYTES CARRYING ANTI-PD-1 SINGLE CHAIN ANTIBODY AND PREPARATION METHOD THEREFOR;
Travel, Accommodations, Expenses - Westlake Therapeutics; Westlake Therapeutics